"10.1371_journal.pone.0087712","plos one","2014-01-31T00:00:00Z","Madeleine White; Gill Webster; David O’Sullivan; Sarrabeth Stone; Anne Camille La Flamme","School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand; Innate Immunotherapeutics, Auckland, New Zealand; Malaghan Institute of Medical Research, Wellington, New Zealand","Conceived and designed the experiments: MW GW DO ACL. Performed the experiments: MW GW DO SS ACL. Analyzed the data: MW GW DO SS ACL. Contributed reagents/materials/analysis tools: GW. Wrote the paper: MW GW ACL.","The authors can affirm that they have read the journal’s policy and have the following conflicts. GW is an employee of Innate Immunotherapeutics, which is commercializing MIS416 as an immune modulator for secondary progressive multiple sclerosis. However, this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Madeleine White","MW",5,TRUE,4,5,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
